To evaluate the therapeutic potential of H2S-releasing aspirin, MZe786, in preeclampsia, Hmox1+/− mice were injected with Ad-sFlt-1 on day E11.5 and simultaneously given four treatment regimens (drug carrier, MZe786, MZe486 or aspirin). Here, HMOX1 is linked to preeclampsia.